Table 1. Characteristics of Patients from Whom Intestine Was Evaluated.

	Non-IBD	UC	Crohn's
Age: mean (range), yrs	45 (18–80)	43 (20–70)	40 (25–67)
% male	33%	43%	25%
IBD duration: median (range), yrs	n/a	3 (0.7–10)	12 (4.7–56)
% on steroids	n/a	71%	38%
% on immunomodulators	n/a	14%	50%
% on anti-TNF drugs	n/a	29%	38%
% on 5' ASA drugs	n/a	43%	38%